Science Explorer Back to mapMap
Discussion
Topic · Polyomavirus and related diseases

Most cited papers in Polyomavirus and related diseases

Polyomavirus and related diseases

What are the most cited papers in Polyomavirus and related diseases?

The most cited paper in Polyomavirus and related diseases is "Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review" (Rimda Wanchoo, Sabine Karam, Nupur N. Uppal et al., 2017), with 15,286 citations. Next come "Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures" (5,970) and "CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S" (3,742).

Showing 50 of 99 papers. Every paper with more than 827 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review Rimda Wanchoo, Sabine Karam, Nupur N. Uppal et al. · American Journal of Nephrology ReviewOpen access 2017 15,286
2 Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures Peter Pushko, Paul Pumpens, Elmars Grens · Intervirology Open access 2013 5,970
3 CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S Harold Glucksberg, Rainer Storb, A Fefer et al. · Transplantation Oct 1974 3,742
4 Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma Huichen Feng, Masahiro Shuda, Yuan Chang et al. · Science Open access 17 Jan 2008 3,242
5 SV40-transformed simian cells support the replication of early SV40 mutants Yakov Gluzman · Cell 1981 2,472
6 Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis Lawrence D. Jacobs et al. · Annals of Neurology Mar 1996 2,458
7 T antigen is bound to a host protein in SY40-transformed cells David Philip Lane, Lionel Vivian Crawford · Nature Mar 1979 2,445
8 Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) Christer Sundström, Kenneth Nilsson · International Journal of Cancer 15 May 1976 2,436
9 Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis Stephen L. Hauser et al. · New England Journal of Medicine Open access 21 Dec 2016 2,042
10 HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide Leo Luznik et al. · Transplantation and Cellular Therapy Open access 18 May 2008 1,953
11 Infection in Solid-Organ Transplant Recipients Jay Alan Fishman · New England Journal of Medicine 19 Dec 2007 1,947
12 Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology Jul 1995 1,906
13 Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012 Howard W. Rogers, Martin A. Weinstock, Steven R. Feldman et al. · JAMA Dermatology Open access 30 Apr 2015 1,846
14 Targeting DNA topoisomerase II in cancer chemotherapy John L. Nitiss · Nature reviews. Cancer ReviewOpen access 20 Apr 2009 1,827
15 Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective Marcie Riches Tomblyn, Tom M Chiller, Hermann Einsele et al. · Transplantation and Cellular Therapy Open access 10 Sep 2009 1,802
16 The Tuberous Sclerosis Complex Peter B. Crino, Katherine L. Nathanson, Elizabeth P. Henske · New England Journal of Medicine 27 Sep 2006 1,793
17 Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual William M. Lydiatt, Snehal G. Patel, Brian P O'Sullivan et al. · CA A Cancer Journal for Clinicians Open access 27 Jan 2017 1,687
18 Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34 Marjon van Slegtenhorst et al. · Science 8 Aug 1997 1,675
19 CULTIVATION OF PAPOVA-LIKE VIRUS FROM HUMAN BRAIN WITH PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY BillieL. Padgett, G. M. ZuRhein, D. L. Walker et al. · The Lancet Jun 1971 1,637
20 Infection in Organ-Transplant Recipients Jay Alan Fishman, Robert H. Rubin · New England Journal of Medicine 11 Jun 1998 1,634
21 Possible Emergence of New Geminiviruses by Frequent Recombination Malla Padidam, Stanley A. Sawyer, Claude Fauquet · Virology Open access Dec 1999 1,621
22 Skin Cancers after Organ Transplantation Sylvie Euvrard, Jean Kanitakis, A Claudy · New England Journal of Medicine 23 Apr 2003 1,599
23 Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence Jacobo Sellarés, Declan G. de Freitas, Michael Mengel et al. · American Journal of Transplantation Open access 14 Nov 2011 1,597
24 Papillomaviruses in the causation of human cancers — a brief historical account Harald zur Hausen · Virology Open access 9 Jan 2009 1,562
25 Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Chantale T. Guy, Robert D. Cardiff, William J. Muller · Molecular and Cellular Biology Open access Mar 1992 1,554
26 Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients Eric A. Engels et al. · JAMA Open access Nov 2011 1,532
27 Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients H-J Kolb, J. Mittermüller, Ch. Clemm et al. · Blood 15 Dec 1990 1,521
28 Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis Lawrence D. Jacobs, Roy W. Beck, Jack H. Simon et al. · New England Journal of Medicine Open access 28 Sep 2000 1,514
29 Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia Rainer F Storb et al. · New England Journal of Medicine 20 Mar 1986 1,461
30 Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence Wen‐Hwa Lee, Robert Bookstein, Frank Hong et al. · Science 13 Mar 1987 1,438
31 Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study Louise Arseneault, Mary D Cannon, Richie Poulton et al. · BMJ Open access 21 Nov 2002 1,410
32 Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Peter A. McSweeney et al. · Blood Jun 2001 1,398
33 Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients William D. Snider, David Martin Simpson, Surl L. Nielsen et al. · Annals of Neurology Oct 1983 1,377
34 Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis Richard A. Rudick, William H. Stuart, Peter A. Calabresi et al. · New England Journal of Medicine Open access Mar 2006 1,347
35 Sequence requirements for nuclear location of simian virus 40 large-T antigen Daniel Kalderon, William David Richardson, Alexander F. Markham et al. · Nature 6 Sep 1984 1,331
36 Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors Margot Thome, Pascal Schneider, Kay Hofmann et al. · Nature Open access 3 Apr 1997 1,326
37 Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells John L. Yates, Noreen Warren, Bill Sugden · Nature Feb 1985 1,302
38 Nasopharyngeal carcinoma Melvin L.K. Chua, Joseph Tien Seng Wee, Edwin Pun Hui et al. · The Lancet 28 Aug 2015 1,282
39 REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY Thomas E. Starzl, Kristen A. Porter, Shunzaburo Iwatsuki et al. · The Lancet Open access Mar 1984 1,276
40 Outcome of Cord-Blood Transplantation from Related and Unrelated Donors Éliane Gluckman, Vanderson Rocha, Agnès Boyer-Chammard et al. · New England Journal of Medicine Open access 7 Aug 1997 1,266
41 PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma Paul Nghiem et al. · New England Journal of Medicine Open access 19 Apr 2016 1,263
42 Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx Harald zur Hausen, Heinrich Schulte‐Holthausen, George Joseph Klein et al. · Nature Dec 1970 1,262
43 Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy Gary Bloomgren, Sandra Richman, Christophe Hotermans et al. · New England Journal of Medicine Open access 17 May 2012 1,255
44 Polyoma transformation of hamster cell clones—an investigation of genetic factors affecting cell competence Ian Macpherson, M. G. P. Stoker · Virology Feb 1962 1,236
45 Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial Howard L. Kaufman, Jeffery Scott Russell, Omid Hamid et al. · The Lancet Oncology Open access 7 Sep 2016 1,235
46 Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients Hans Hellmuth Hirsch, Wendy A. Knowles, Michael Dickenmann et al. · New England Journal of Medicine Open access 15 Aug 2002 1,227
47 Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial Jeffrey A. Cohen, Alasdair J. Coles, Douglas Lorne Arnold et al. · The Lancet Nov 2012 1,214
48 Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alasdair J. Coles, Cary L. Twyman, Douglas Lorne Arnold et al. · The Lancet Open access Nov 2012 1,206
49 Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death S. A. Henderson, Martin Rowe, C D Gregory et al. · Cell Jun 1991 1,190
50 Cancer Incidence Before and After Kidney Transplantation Claire Melissa Vajdic, Stephen Peter McDonald, Margaret R.E. McCredie et al. · JAMA 19 Dec 2006 1,135

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.